共 63 条
[1]
Jackson DW(2001)Symptomatic articular cartilage degeneration: the impact in the new millennium Clin Orthop 391 S14-S25
[2]
Simon TM(1993)Viscosupplementation: a new concept in the treatment of osteoarthritis J Rheumatol Suppl 39 3-9
[3]
Aberman HM(1987)The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment Rheumatol Int 7 113-122
[4]
Balazs EA(1998)Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group J Rheumatol 25 2203-2212
[5]
Denlinger JL(1993)The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation J Rheumatol Suppl 39 19-24
[6]
Smith MM(1992)Inhibitory effects of hyaluronan on [14C]arachidonic acid release from labeled human synovial fibroblasts Jpn J Pharmacol 60 79-84
[7]
Ghosh P(1980)Inhibition of phagocytosis by high molecular weight hyaluronate Immunology 40 435-446
[8]
Altman RD(1994)Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH.) radicals is dependent on hyaluronan molecular mass Cell Biochem Funct 12 281-288
[9]
Moskowitz R(1994)The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid Clin Exp Rheumatol 12 75-82
[10]
Pelletier JP(1997)Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative Exp Brain Res 116 3-9